BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37582796)

  • 21. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
    Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
    Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.
    Jovel IT; Mejía RE; Banegas E; Piedade R; Alger J; Fontecha G; Ferreira PE; Veiga MI; Enamorado IG; Bjorkman A; Ursing J
    Malar J; 2011 Dec; 10():376. PubMed ID: 22183028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
    Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
    Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China-Myanmar border.
    Zhao Y; Wang L; Soe MT; Aung PL; Wei H; Liu Z; Ma T; Huang Y; Menezes LJ; Wang Q; Kyaw MP; Nyunt MH; Cui L; Cao Y
    Malar J; 2020 Aug; 19(1):281. PubMed ID: 32758218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Mandliya J; Sharma A; Diwan V; Ursing J
    Malar J; 2014 May; 13():182. PubMed ID: 24885535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Epidemiology of Drug Resistance Genes in Plasmodium falciparum Isolates Imported from Nigeria between 2016 and 2020: Continued Emergence of Fully Resistant
    Wang X; Zhang X; Chen H; Zhang J; Lu Q; Ruan W; Ling F
    Microbiol Spectr; 2022 Oct; 10(5):e0052822. PubMed ID: 36106887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
    Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
    Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H
    Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.
    Fall B; Pascual A; Sarr FD; Wurtz N; Richard V; Baret E; Diémé Y; Briolant S; Bercion R; Wade B; Tall A; Pradines B
    Malar J; 2013 Mar; 12():107. PubMed ID: 23510258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
    Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
    Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
    Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular detection of drug resistant malaria in Southern Thailand.
    Noisang C; Prosser C; Meyer W; Chemoh W; Ellis J; Sawangjaroen N; Lee R
    Malar J; 2019 Aug; 18(1):275. PubMed ID: 31416468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistance profile and clonality of Plasmodium falciparum parasites in Cape Verde: the 2017 malaria outbreak.
    Da Veiga Leal S; Ward D; Campino S; Benavente ED; Ibrahim A; Claret T; Isaías V; Monteiro D; Clark TG; Gonçalves L; Valdez T; da Luz Lima Mendonça M; Silveira H; Nogueira F
    Malar J; 2021 Mar; 20(1):172. PubMed ID: 33789667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
    Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
    Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and temporal changes of mutations linked to antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Palawan, Philippines.
    Bareng APN; Grignard L; Reyes R; Fornace K; Spencer F; Macalinao ML; Luchavez J; Espino FE; Drakeley C; Hafalla JCR
    Int J Infect Dis; 2022 Mar; 116():174-181. PubMed ID: 34883232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction.
    Lo E; Nguyen J; Oo W; Hemming-Schroeder E; Zhou G; Yang Z; Cui L; Yan G
    BMC Infect Dis; 2016 Apr; 16():154. PubMed ID: 27084511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.